Not provided
Not provided
Not provided
Not provided
Not provided
Discontinued relationship with vendor. Currently investigating alternatives.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Xemed LLC | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Thoracic insufficiency syndrome (TIS) is a complex condition that involves chest wall deformities that can affect normal breathing and lung growth. In most cases, children with TIS are also born with spine disorders such as scoliosis. The inability of the thorax to support normal respiration or lung growth can cause respiratory distress and even mortality. Investigators aim to validate MRI imaging sequences to use as an assessment tool for pulmonary function.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Thoracic Insufficiency Group | Other | Thoracic insufficiency syndrome patients undergoing surgery |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Xenon-129 | Device | Patients will undergo a hyperpolarized MRI with administered Xenon gas |
|
| Measure | Description | Time Frame |
|---|---|---|
| Analyze volume of lungs at end-inspiration and end-expiration | Investigators will analyze lung volume at end-inspiration and end-expiration will be assessed by performing a thoracic dynamic magnetic resonance imaging scan; measured in total volume units (mL) | up to 2 years |
| Xenon-129 MRI Ventilation Maps | Xenon-129 MRI will be completed to reveal unventilated regions of the lungs where the gas cannot reach after being inhaled due to restrictions of the airways. | up to 2 years |
| Measure | Description | Time Frame |
|---|---|---|
| oxygen partial pressure (PAO2) maps | Oxygen partial pressure (PAO2) maps will be extracted from 129Xe MRI maps in a single breath-hold. Regions of the lungs that show abnormal PAO2 values are susceptible of improper ventilation or gas exchange. | up to 2 years |
| Forced vital capacity (FVC) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Patrick Cahill, MD | Children's Hopsital of Philadelphia | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Forced vital capacity will be extracted from the computer-automated dynamic lung MRI software. |
| up to 2 years |
| Forced expiratory volume (FEV1) | Forced expiratory volume data will be extracted from the computer-automated dynamic lung MRI software to assess the volume of air forced from the lungs | up to 2 years |
| Xenon-129 MRI apparent diffusion coefficient (ADC) maps | Apparent diffusion coefficient (ADC) maps are extracted from the Xenon-129 MRI from a single breath-hold pulse sequence. | up to 2 years |
| total lung capacity | Total lung capacity will be extracted from the computer-automated dynamic lung MRI software. | up to 2 years |
| functional residual capacity (FRC) | functional residual capacity data will be extracted from the computer-automated dynamic lung MRI software to measure the volume in the lungs at the end of passive expiration | up to 2 years |